Swiss National Bank Celldex Therapeutics, Inc. Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 115,900 shares of CLDX stock, worth $3.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115,900
Previous 114,300 1.4%
Holding current value
$3.26 Million
Previous $4.23 Million 6.93%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$32.06 - $44.56 $51,296 - $71,296
1,600 Added 1.4%
115,900 $3.94 Million
Q1 2024

May 07, 2024
BUY
$35.22 - $51.88 $609,306 - $897,524
17,300 Added 17.84%
114,300 $4.8 Million
Q4 2023

Feb 06, 2024
BUY
$22.61 - $40.65 $196,707 - $353,655
8,700 Added 9.85%
97,000 $3.85 Million
Q3 2023

Nov 08, 2023
BUY
$25.45 - $37.46 $22,905 - $33,714
900 Added 1.03%
88,300 $2.43 Million
Q2 2023

Aug 09, 2023
BUY
$30.29 - $38.28 $181,740 - $229,680
6,000 Added 7.37%
87,400 $2.97 Million
Q1 2023

May 10, 2023
SELL
$34.78 - $47.43 $309,542 - $422,127
-8,900 Reduced 9.86%
81,400 $2.93 Million
Q4 2022

Feb 08, 2023
BUY
$27.78 - $45.38 $58,338 - $95,298
2,100 Added 2.38%
90,300 $4.02 Million
Q1 2022

May 09, 2022
BUY
$27.64 - $39.32 $174,132 - $247,716
6,300 Added 7.69%
88,200 $3 Million
Q4 2021

Feb 08, 2022
SELL
$35.68 - $56.27 $121,312 - $191,318
-3,400 Reduced 3.99%
81,900 $3.17 Million
Q3 2021

Nov 08, 2021
SELL
$28.95 - $55.99 $55,005 - $106,381
-1,900 Reduced 2.18%
85,300 $4.61 Million
Q2 2021

Aug 06, 2021
SELL
$20.71 - $35.37 $66,272 - $113,183
-3,200 Reduced 3.54%
87,200 $2.92 Million
Q1 2021

May 07, 2021
BUY
$16.19 - $29.91 $30,761 - $56,829
1,900 Added 2.15%
90,400 $1.86 Million
Q4 2020

Feb 05, 2021
BUY
$14.99 - $22.75 $1.33 Million - $2.01 Million
88,500 New
88,500 $1.55 Million

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.32B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email